NOTCH4 and COVID-19: In a prospective cohort of COVID-19 patients, the expression of Notch-4 in circulating Tregs increased, which suppressed the release of IL-18 induced AREG, thus restraining AREG-dependent tissue repair and promoting severe lung injury [42].